Objective-Modifications
C ardiovascular disease (CVD) continues to be the major cause of morbidity and mortality in the developed world 1 and is rapidly becoming a key determinant of premature death in developing nations. Known risk factors, such as lipid and inflammatory genes and biomarkers, predict a relatively small fraction of risk, and additional insights are needed to identify all determinants of CVD risk. 2 This is particularly true among sexes, as well as certain ethnic groups, where similarly potent risk factors do not seem to have the same impact. 1, [3] [4] [5] [6] It has been established that atherosclerosis, the main etiologic driver of CVD, is primarily a disease of lipid abnormalities with superimposed chronic inflammation. Modification of the lipid constituents within atherosclerotic lesions generates neoepitopes, called danger-associated molecular patterns, 7 that activate innate and adaptive immune responses. These responses initiate a proinflammatory response to inactivate and clear such antigens. 8, 9 The generation of proinflammatory oxidation-specific epitopes (OSE) in vivo is well described. 10 At the clinical level, one can measure plasma IgG and IgM autoantibodies that target chemically and pathophysiologically well-defined OSE, such as malondialdehyde-lysine adducts on proteins. IgG and IgM present on apolipoprotein B-100 lipoproteins as part of immune complexes can also be measured. 11, 12 In general, elevated plasma levels of IgG autoantibodies to OSE represent responses to antigen exposure and tend to correlate with worse cardiovascular risk. In contrast, IgM autoantibodies to OSE often represent natural antibodies present at birth that are likely evolutionarily conserved to protect against such danger-associated molecular patterns present in sites of inflammation, such as apoptotic cells and cell walls of infectious pathogens. These so-called natural antibodies also bind to OSE on modified lipoproteins because the target, danger-associated molecular patterns, are either identical or act as molecular mimics of those present on apoptotic cells and infectious agents. 9, 13 In contrast to IgGs to OSE, IgMs tend to be associated with lower CVD events. 11, 12, 14, 15 The prevalence and impact on subclinical and clinical CVD of such biomarkers of oxidized lipoproteins in different sexes and ethnicities have not been well studied. Because the titers of OSE autoantibodies are strongly influenced by heredity, 16 it might be anticipated that sex/ethnic differences might have an important impact on their titers. Therefore, the purpose of this study is to examine the relationship between IgG and IgM autoantibodies to malondialdehyde-modified low-density lipoprotein (MDA-LDL) and apolipoprotein B-100-immune complexes (apoB-IC) and subclinical atherosclerosis and major adverse cardiovascular events (MACE) during a 10.5-year prospective follow-up in a large, multi-ethnic, population-based epidemiological cohort from the Dallas Heart Study (DHS).
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

Subject Characteristics
The participant characteristics in the entire group combined and by ethnicity are summarized in Table 1 . The study consisted of 3509 participants, with a mean age of 43.7±10.1 years and 44.1% of the subjects were men, 1814 (51.7%) were black, 1021 (29.1%) were white, and 589 (16.8%) were Hispanic. Eighty-five subjects did not self-report ethnicity. Significant differences were observed in baseline characteristics between ethnic groups. There was a high prevalence of traditional cardiovascular risk factors in the population: 34.4% hypertension, 11.6% diabetes mellitus, and 29.3% current smokers. Notably, blacks had the lowest total cholesterol, triglycerides, and very-low-density lipoprotein cholesterol levels and highest high-density lipoprotein cholesterol levels. Low-density lipoprotein cholesterol levels were comparable among the 3 ethnic groups. Hispanics had a lower prevalence of current smoking, and blacks had the highest prevalence of hypertension. Significant differences were also noted among autoantibodies and apoB-IC, with blacks having highest levels of IgG MDA-LDL and IgG apoB-IC and Hispanics having the highest levels of IgM apoB-IC, measured as relative light units (Table 1) In the entire group, IgG MDA-LDL and IgG apoB-IC levels tended to be higher with advancing age, and IgM MDA-LDL and IgM apoB-IC tended to be lower with age ( Figure 1 ). Comparing biomarkers within ethnic groups, in blacks IgG MDA-LDL (P=0.086) and IgG apoB-IC (P=0.002) tended to be higher with age, whereas in contrast IgM MDA-LDL (P=0.03) and IgM apoB-IC (P<0.001) were significantly lower with age. In whites, only IgM apoB-IC (P<0.001) was lower with age, but in Hispanics both IgG MDA-LDL (P=0.007) and IgM apoB-IC (P<0.001) were significantly lower with age (Table 2) . Table I in the online-only Data Supplement shows the median (interquartile range) levels of the autoantibody titers and apoB-immune complexes in patients according to sex. Women of all ethnicities tended to have higher IgM MDA-LDL and apoB-IC levels. Table II in the online-only Data Supplement shows the median (interquartile range) levels of autoantibody titers and apoB-immune complexes in patients according to demographic variables. Diabetic subjects had lower levels of IgM MDA-LDL and IgM apoB-IC, and subjects with hypertension had higher levels of IgG MDA-LDL but lower levels of IgG apoB-IC. Seventy-five individuals either did not have ethnicity identified or identified as other and were not included in the ethnicity analysis. apoB-IC indicates apolipoprotein B-100-immune complexes; BMI, body mass index; HDL-C, high-density lipoprotein cholesterol; HTN, hypertension; LDL-C, low-density lipoprotein cholesterol; MDA-LDL, malondialdehyde-modified low-density lipoprotein; RLU, relative light unit; and VLDL-C, very-low-density lipoprotein cholesterol. *In the database, of the 3509 individuals, 3419 had an entry for prevalent hypertension. When using CAC >10 as a positive score and CAC <10 as a negative score to remove artifact bias of low CAC scores and evaluating the data with binary logistic analysis with multivariable adjustment with the variables in Table 1 (age per decile, male sex, ethnicity, diabetes mellitus, current smoking, body mass index, low-density lipoprotein cholesterol per SD, high-density lipoprotein per SD, log triglycerides per SD, hypertension, and log of the 4 oxidative biomarker variables per SD), the log IgG MDA-LDL per 1 SD odds ratio (95% confidence interval [CI]) was 1.21 (1.07-1.36; P=0.002) and log IgG apoB-IC per 1 SD was 0.88 (0.79-0.99; P=0.026) and were independently associated with CAC >10 (Table 3 ). The P value for the interaction test of ethnicity (included all 3 groups)*log IgG MDA-LDL per 1 SD was P=0.27. Evaluating these data by ethnicity, similar trends were noted (Table IV in the online-only Data Supplement).
For abdominal aortic atherosclerosis measured as aortic plaque burden by magnetic resonance imaging, 977 (39.5%) of 2475 had a positive scan. Weak but significant positive correlations were noted with IgG MDA-LDL (r=0.053; P=0.009), and inverse correlations were noted with IgG apoB-IC (r=−0.048; P=0.017) and IgM apoB-IC (r=−0.094; P<0.001).
When using plaque area equal to 0 or >0 mm 2 as a binary variable in a multivariable, logistic regression analysis, including variables in Table 1 (Table 3 ). The P value for the interaction test of ethnicity (included all 3 groups)*log IgG apoB-IC per 1 SD was P=0. 43 . Evaluating these data by ethnicity, generally similar findings were noted (Table V in the online-only Data Supplement).
Relationship of Biomarkers of Oxidized Lipoproteins to Cardiovascular Outcomes
There were a total of 190 MACE events out of total of 2914 subjects with adjudicated MACE until December 31, 2011, with 132 (of 1498 subjects or 8.81%) in blacks, 44 (of 911 subjects, or 4.83%) in white, and 12 (of 447 subjects, or 2.68%) in Hispanics. There were 2 events in subjects whose ethnicity was not identified and who were not included in the analyses. Cox regression analysis with time to MACE was performed in the entire group in 3 models: model 1, oxidation biomarkers alone; model 2, plus age in deciles, sex, hypertension, diabetes mellitus, current smoking, low-density lipoprotein cholesterol per 1 SD, high-density lipoprotein cholesterol per 1 SD, and log triglycerides per 1 SD; and model 3, plus ethnicity. IgG MDA-LDL were independently associated with time to MACE with a hazard ratio (HR) (95% CI) of 2.10 (1.40-3.15; P=0.001) for fourth quartile versus first (Table 4) . Further adjustment in model 2 and model 3 attenuated the results slightly, but significance was maintained. The ethnicity*quartile IgG MDA-LDL interaction was significant for Q3 (P=0.006) and Q4 (P<0.001) versus Q1. Removing all revascularization events did not appreciably change the HR (95% CI) 1.75 (1.12-2.75; P=0.014) for Q4 versus Q1 in the fully adjusted model. Figure 2A demonstrates the temporal relationship of time to MACE in the entire group for IgG MDA-LDL autoantibodies. The IgM MDA-LDL, IgG apoB-IC, and IgM apoB-IC were not significantly different after full adjustment (Table 4 ). In the model of IgG MDA-LDL Figure 2B through 2D). 
Discussion
This study demonstrates several novel observations on circulating autoantibodies and immune complexes reflecting OSE during a 10.5-year prospective follow-up in the DHS: first, significant differences were present between ethnic groups in several measures, with blacks having highest levels of IgG MDA-LDL and apoB-IC, whereas whites had the lowest levels and Hispanics had the highest levels of IgM apoB-IC; second, a significant age effect was noted, with IgGs trending higher and IgMs lower with advancing age; third, IgG MDA-LDL levels were associated with prevalent CAC; fourth, elevated IgG MDA-LDL levels were predictive of time to MACE in the entire group, an effect particularly prominent in black subjects. Remarkably, these findings were present even though individuals were relatively young (mean age ≈44 years old) on entry into the study.
Because the initial description of autoantibodies to oxidized LDL in atherosclerotic lesions and plasma of both animals and humans, [17] [18] [19] a large database has been generated on experimental 13, 14, 20, 21 and clinical aspects of such autoantibodies. 11, 12, 22, 23 Furthermore, the research realm has expanded beyond CVD to other inflammatory conditions, such as lupus, rheumatoid arthritis, 24 infections, 25 renal failure, 26 and Alzheimer disease. 27 However, most of these studies have been performed in subjects of European descent, and little data are present in other ethnic groups. This is the first dedicated study evaluating autoantibody titers to oxidized lipoproteins and immune complexes with apoB-100 lipoproteins in the context of race and ethnicity. Significant differences in racial/ethnic groups were present, and in turn, higher IgG MDA-LDL titers were associated with higher CAC score and likelihood for MACE. Although the underlying cause of these differences cannot be determined from this study, the data suggest that appropriate interpretation of these measurements in epidemiological studies should include race/ethnicity as a variable.
The association of age with oxidative biomarkers is also of interest, particularly because age is universally one of the strongest risk factors for CVD. The DHS has the advantage of evaluating the relationship of age to these biomarkers because it includes a broad range of 18-to 65-year-old subjects. Although age was analyzed in a cross-sectional rather than a prospective analysis in DHS, one can speculate that continued exposure to the various OSE led to increasing IgG titers as subjects age. Conversely, as IgMs are thought to be derived from B-1 cells present at birth or shortly thereafter, a decline in titers to OSE over time may suggest loss of certain B-1 cell subsets, resulting in decreased innate immune responses to chronic diseases caused by OSE and certain infections. 13, 21, [28] [29] [30] Consistent with a genetic influence of circulating autoantibodies to OSE, a recent genome-wide linkage study and genetic association in twins, the heritabilities (h 2 ) of IgM MDA-LDL and IgM apoB-IC were 0.69 and 0.80, respectively, and for IgG MDA-LDL and apoB-IC were 0.62 and 0.53, respectively, which were similar or higher than physiological, inflammatory, or lipid traits. 16 In this study, IgG MDA-LDL titers were predictive of subclinical atherosclerosis as measured by CAC, which to our knowledge is the first study to evaluate this phenotype with autoantibodies to OSE. This is consistent with some, 12, 18, [31] [32] [33] but not all, [34] [35] [36] studies that show similar associations with carotid or peripheral arterial disease. Analyses by ethnicity showed that this association was only significant in blacks although the interaction test for ethnicity was not significant, but trends across ethnicity were consistent. It is also interesting that blacks in the United States, as reflected in the Dallas area in this study, have up to 25% European or Native American genes, which further complicates analysis based on race/ethnicity. 37 This study also showed that elevated levels of IgG MDA-LDL were independently predictive of time to MACE during a median of 10.5 years, which seemed to be primarily driven by the black cohort. These observations are consistent with the Bruneck study in whites, where IgG titers to Cu-OxLDL (copper-oxidized LDL) were associated with higher risk of MACE (HR, 1.18; 95% CI, 1.02-1.37; P=0.028 for 1-SD unit increase), 12 as well as in other studies. 11, 12, [38] [39] [40] However, these data are not entirely consistent because other studies have shown no association. 11, 36, 39, 41, 42 In addition, a recent study has shown that low levels of IgG to selected apoB-100 peptides and MDA-modified apoB-100 peptides (which may not reflect IgG titers to MDA epitopes) are associated with higher risk of CVD. 43 In a recent report from the DHS, we reported that lipoprotein(a), oxidized phospholipids on apolipoprotein B-100, apolipoprotein(a) isoforms, and LPA snps (single nucleotide polymorphism) varied significantly by ethnicity. In turn, elevated lipoprotein(a) and oxidized phospholipids on apolipoprotein B-100 were independent predictors of MACE, even after adjusting for apolipoprotein(a) isoforms and LPA snps with consistent results in the 3 ethnic groups. 44 IgM biomarkers in this study were not predictive of CVD events. In other studies, low levels of IgM autoantibodies to a variety of OSE predict worse outcomes, 12, 45 consistent with a potentially atheroprotective effect, which has been consistently observed in experimental studies (reviewed in 9, 22 ) In DHS, with a decline in IgM levels in more advanced ages, power may not have been optimal to assess these relationships, compared with prior studies that recruited more elderly individuals.
The underlying reasons for the divergent results in these studies are not clear, but our current observations suggest that the failure to consider ethnic/race of the populations studied may be one such factor. Aside from other biases in the populations studied, study design, methodological assessments of subclinical atherosclerosis end points, and different end points confound these studies. In addition, there are likely multiple technical issues in the way these antibody titers were assessed, including differences in assay antigen preparation. It is well known that variations in the extent of oxidation result in different preparations of MDA-LDL, or other MDA-modified proteins, which can result in differences in measured autoantibody titers. 46, 47 The generation of standardized antigens has been suggested to overcome this limitation and standardize assays across laboratories. In that regard, we have described the development of small amino acid mimotopes apparently reflecting the 3-dimensional structure of MDA and validated that they have similar immunologic properties of MDA and may be useful in future studies. 48 Ultimately, whether such autoantibody titers to OSE are causally related to CVD or are epiphenomena await genome-wide association and other studies evaluating causality. For example, a recent genome-wide association study using the PROMIS (Pakistan Risk of Myocardial Infarction Study) database showed that novel variants on chromosome 6 at the HLA-B (human leukocyte antigen-B) locus and on chromosome 12 at the CIT locus were associated with circulating IgM titers to MDA-LDL, IgM to phosphocholine-modified BSA, and apoB-IC, and these variants were subsequently linked to CVD events in PROMIS, as well as in the CARDIoGRAMplusC4D consortium database. 49 These clinical observations in conjunction with experimental data strongly suggest genetic influences on circulating levels of autoantibody titers to OSE, which may then be reflected as differences in circulating levels among different ethnic groups, and finally to cardiovascular events.
Limitations of this study included that the Hispanic group was small with a relatively small number of events and therefore the study may have been underpowered to evaluate relationships to CVD.
In conclusion, significant age and ethnic-specific difference are present in IgG and IgM autoantibody titers to OSE and apoB-IC. Elevated IgG MDA-LDL is associated with time to MACE, particularly in black individuals and may provide some explanations for the disparity in outcomes among different ethnic groups.
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